<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65649">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02154438</url>
  </required_header>
  <id_info>
    <org_study_id>3-2014-0062</org_study_id>
    <nct_id>NCT02154438</nct_id>
  </id_info>
  <brief_title>The Effect of Ketamine Infusion on Lumbar Surgery</brief_title>
  <official_title>The Effect of Ketamine Infusion for Reduction of Neuropathic Pain and Improvement of Quality of Life After Lumbar Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>South Korea: Korea Food and Drug Administration (KFDA)</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of ketamine infusion for reduction of
      neuropathic pain and improvement of quality of life after lumbar surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuropathic pain defined as 'pain caused by a lesion or disease of the somatosensory
      system'. Neuropathic pain is 20 - 35% of low back pain.

      Ketamine is categorized as N-methyl D-aspartate receptor antagonist. Ketamine has an
      analgesic effect in low dose and anesthetic effect in relative high dose. Also, ketamine is
      used in chronic neuropathic pain as postherpetic neuralgia., phantom pain, central
      neuropathic pain, complex regional pain syndrome, ischemic pain.

      In this study, ketamine will be infused during lumbar surgery in randomized, double-blind
      and double-blind parallel group control trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain Scores on the Visual Analog Scale</measure>
    <time_frame>1 day before lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS score in 1 day before lumbar surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Scores on the Visual Analog Scale</measure>
    <time_frame>1 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS score in 1 month after lumbar surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Scores on the Visual Analog Scale</measure>
    <time_frame>3 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS score in 3 month after lumbar surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leeds assessment of neuropathic symptoms and signs (LANSS) score</measure>
    <time_frame>1 day before lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>LANSS score in 1 day before lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leeds assessment of neuropathic symptoms and signs (LANSS) score</measure>
    <time_frame>1 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>LANSS score in 1 month after lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leeds assessment of neuropathic symptoms and signs (LANSS) score</measure>
    <time_frame>3 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>LANSS score in 3 month after lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neuropathic pain scale (NPS) score</measure>
    <time_frame>1 day before lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>NPS score in 1 day before lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neuropathic pain scale (NPS) score</measure>
    <time_frame>1 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>NPS score in 1 month after lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neuropathic pain scale (NPS) score</measure>
    <time_frame>3 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>NPS score in 3 month after lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry disability index (ODI) score</measure>
    <time_frame>1 day before lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>ODI score in 1 day before lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry disability index (ODI) score</measure>
    <time_frame>1 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>ODI score in 1 month after lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry disability index (ODI) score</measure>
    <time_frame>3 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>ODI score in 3 month after lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WHO Quality of Life (WHOQOL-BREF) score</measure>
    <time_frame>1 day before lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>WHOQOL-BREF score in 1 day before lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WHO Quality of Life (WHOQOL-BREF) score</measure>
    <time_frame>1 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>WHOQOL-BREF score in 1 month after lumbar surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WHO Quality of Life (WHOQOL-BREF) score</measure>
    <time_frame>3 month after lumbar surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>WHO Quality of Life (WHOQOL-BREF) score in 3 month after lumbar surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ketamine 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>ketamine 0.5mg/kg loading followed by 0.5mg/kg/h infusion during operation</description>
    <arm_group_label>ketamine</arm_group_label>
    <other_name>Huons ketamine hch injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing lumbar spine surgery due to back pain patients

          -  American Physical Status Classification I or II

        Exclusion Criteria:

          -  less than 3 month of back pain

          -  past history of operation at lumbar area

          -  past history of glucoma, drug abuse, alcohol abuse

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyung Hyun Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, The Spine and Spinal Cord Institute, Gangnam Severance Spine Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyung Hyun Kim, MD</last_name>
    <phone>82-02-2019-3401</phone>
    <email>NSKHK@yuhs.ac</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cholhee Park, MD</last_name>
    <phone>82-02-2019-6079</phone>
    <email>chairp@yuhs.ac</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>135-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyung Hyun Kim, MD</last_name>
      <phone>82-02-2019-3401</phone>
      <email>NSKHK@yuhs.ac</email>
    </contact>
    <contact_backup>
      <last_name>Cholhee Park, MD</last_name>
      <phone>82-02-2019-6079</phone>
      <email>chairp@yuhs.ac</email>
    </contact_backup>
    <investigator>
      <last_name>Cholhee Park, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 29, 2014</lastchanged_date>
  <firstreceived_date>May 25, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yonsei University</investigator_affiliation>
    <investigator_full_name>Cholhee Park</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
